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OBJECTIVES We sought to characterize an animal model of the Wolff-Parkinson-White (WPW)
syndrome to help elucidate the mechanisms of accessory pathway formation.
BACKGROUND Patients with mutations in PRKAG2 manifest cardiac hypertrophy and ventricular pre-
excitation; however, the mechanisms underlying the development and conduction of
accessory pathways remain unknown.
METHODS We created transgenic mice overexpressing either the Asn488Ile mutant (TGN488I) or
wild-type (TGWT) human PRKAG2 complementary deoxyribonucleic acid under a cardiac-
specific promoter. Both groups of transgenic mice underwent intracardiac electrophysiologic,
electrocardiographic (ECG), and histologic analyses.
RESULTS On the ECG, 50% of TGN488I mice displayed sinus bradycardia and features suggestive of
pre-excitation, not seen in TGWT mice. The electrophysiologic studies revealed a distinct
atrioventricular (AV) connection apart from the AV node, using programmed stimulation. In
TGN488I mice with pre-excitation, procainamide blocked bypass tract conduction, whereas
adenosine infusion caused AV block in TGWT mice but not TGN488I mice with pre-
excitation. Serial ECGs in 16 mice pups revealed no differences at birth. After one week, two
of eight TGN488I pups had ECG features of pre-excitation, increasing to seven of eight pups
by week 4. By nine weeks, one TGN488I mouse with WPW syndrome lost this phenotype,
whereas TGWT pups never developed pre-excitation. Histologic investigation revealed
postnatal development of myocardial connections through the annulus fibrosum of the AV
valves in young TGN488I but not TGWT mice.
CONCLUSIONS Transgenic mice overexpressing the Asn488Ile PRKAG2 mutation recapitulate an electro-
physiologic phenotype similar to humans with this mutation. This includes procainamide-
sensitive, adenosine-resistant accessory pathways induced in postnatal life that may rarely
disappear later in life. (J Am Coll Cardiol 2003;42:942–51) © 2003 by the American
College of Cardiology Foundation
Wolff-Parkinson-White (WPW) syndrome or other su-
praventricular tachycardias (SVTs) typically occur without
obvious monogenic inheritance patterns. However, genetic
mutations play a role in the development of some cases of
WPW syndrome. Families with WPW syndrome and/or
SVT, with or without hypertrophic cardiomyopathy, are
described (1). The frequency of SVT in certain congenital
heart defects and mitochondrial disorders implicates muta-
tions that disrupt both cardiac structural and electrical
system development (2,3). Although most patients with
WPW syndrome have structurally normal hearts, a subset
exists with ventricular pre-excitation, intraventricular con-
duction delay, and cardiac hypertrophy with familial occur-
rence. Recently, Gollob et al. (4) and Arad et al. (5)
described families with profound conduction disorders and
WPW syndrome with (4,5) and without (6) ventricular
hypertrophy. Several missense mutations in PRKAG2, the
gene for the gamma-2 regulatory subunit of adenosine
monophosphate (AMP)-activated protein kinase, were identi-
fied. To better understand the molecular and physiologic
mechanisms underlying this inherited form of ventricular
pre-excitation, transgenic mice were created by overexpressing
the wild-type or mutant human PRKAG2 complementary
deoxyribonucleic acid (Asn488Ile) under the cardiac-specific
alpha-myosin heavy chain (MHC) promoter (7).
We describe here the natural history, developmental
maturation, electrophysiology, and pharmacology of acces-
sory atrioventricular (AV) connections in a murine model
that recapitulates the clinical profile from which the muta-
tion was derived. Our data provide evidence that an
adenosine-resistant, procainamide-sensitive AV connection,
apart from the normal AV node-His pathway, is present in
From the *Molecular Cardiology Research Center and Section of Cardiac Elec-
trophysiology, University of Pennsylvania, Philadelphia, Pennsylvania; †Department
of Genetics, Harvard Medical School and Howard Hughes Medical Institute, Boston,
Massachusetts; ‡Department of Pathology and Cardiac Registry, Children’s Hospital,
Boston, Massachusetts; §Department of Cardiology, Children’s Hospital and De-
partment of Pediatrics, Harvard Medical School, Boston, Massachusetts; Division of
Cardiology, Brigham and Women’s Hospital, Boston, Massachusetts. Drs. J. Seid-
man, C. Seidman, and I. Moskowitz were supported by the Howard Hughes Medical
Institute. Dr. Berul was supported by the Children’s Hospital Research Foundation.
Drs. Patel and Arad contributed equally to this work.
Manuscript received December 26, 2002; revised manuscript received May 8, 2003,
accepted May 21, 2003.
Journal of the American College of Cardiology Vol. 42, No. 5, 2003
© 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00
Published by Elsevier Inc. doi:10.1016/S0735-1097(03)00850-7
mice carrying the mutant transgene, and these accessory AV
connections manifest in postnatal life.
METHODS
Animals. Creation of transgenic mice was recently de-
scribed (7). Surface electrocardiograms (ECGs) were ob-
tained for 28 transgenic mutant PRKAG2 (TGN488I) mice
(4 to 16 weeks old), 13 age-matched transgenic wild-type
PRKAG2 (TGWT) mice, and 13 control nontransgenic
mice. A subset (n  26) underwent in vivo electrophysi-
ologic studies (EPS) with pharmacologic testing. A group of
10 older TGN488I mice (9 to 15 months old) and 10
littermate controls also underwent ECG and EPS. Finally,
serial ECGs were obtained weekly from birth to 12 weeks in
a cohort of 16 mice from two litters. Mice were inbred in an
FVB background and are genetically equivalent. All proto-
cols conformed to the Association for the Assessment and
Accreditation of Laboratory Animal Care and the Chil-
dren’s Hospital Animal Care and Use Committee.
Preprocedural preparation. Protocols for the in vivo
mouse EPS have been described in detail (8,9). Mice were
anesthetized with pentobarbital (0.033 mg/kg intraperitoneal-
ly), and multilead ECGs were obtained using subcutaneous
electrodes. A jugular vein cutdown was performed, and an
octapolar 2F electrode catheter (CIBer mouse-EP;
NuMED, Inc., Hopkinton, New York) was placed in the
right atrium and ventricle under electrographic guidance to
confirm the catheter position.
EPS. In vivo EPS were performed in 26 mice (17 TGN488I
and 9 TGWT mice). Standard pacing protocols were used to
assess atrial and ventricular conduction, refractoriness, and
arrhythmia inducibility (8,9). The ECG channels were
filtered between 0.5 and 250 Hz, and intracardiac electro-
grams were filtered between 5 and 400 Hz. The analog
signal was digitized with 12-bit precision at a sampling rate
of 2 kHz. Recording of a triphasic His-bundle electrogram
(HBE), a fixed distance from the ventricular electrogram at
baseline, was accomplished using simultaneous multielec-
trodes and persistent catheter manipulation (9). The ECG
intervals were measured in six limb leads and precordial V
leads by two observers who were blinded to the genotype.
To assess the presence of an accessory AV connection,
adenosine (0.5 g/g intravenously [IV]) was administered
during steady-rate atrial pacing, followed by ventricular
pacing. Isoproterenol was administered (1 ng/g IV) and the
EPS repeated after a 25% heart rate increase. Procainamide
was administered (30 g/g IV) to assess the effects of
increased refractoriness and slowed conduction upon the
accessory AV connection and arrhythmia inducibility. In the
older group of mice, after baseline electrophysiologic pa-
rameters were recorded, carbamyl choline (CCh) was ad-
ministered (50 ng/g IP). The atrial pacing protocol was
repeated 5 min after CCh to assess muscarinic modulation
and attempt atrial fibrillation induction to measure acces-
sory pathway conduction characteristics (10).
ECG vector analysis. Electrocardiographic “delta” wave
vector analysis was performed according to a method mod-
ified from Arruda et al. (11). Onset of ventricular activation
in each ECG lead, determined by two observers, was
measured from the onset of the earliest delta wave. The
polarity of the delta wave was measured within the first 5 ms
of the onset of pre-excitation.
Histology and morphology. Hearts were excised from
TGN488I, TGWT, and wild-type mice, washed in Dulbecco’s
phosphate-buffered saline, arrested in 50 mmol/l KCl, and
formalin-fixed (12). Intact hearts were serially sectioned
(5 M) in the sagittal plane and stained with Masson
trichrome to allow visualization of the annulus fibrosum of
the AV valves. Sections were analyzed on a compound
microscope and digitally photographed. Hearts were ana-
lyzed by an experienced cardiac pathologist who was blinded
to the genotype and ECG.
Statistical analysis. Continuous variables, such as ECG
intervals and conduction parameters, were measured by two
observers and summarized as the mean value  SD. Mean
values for TGN488I mice with and without pre-excitation
were compared with control values, using one-way analysis
of variance followed by the Scheffe´ method of multiple
comparisons. The Fisher exact test was used for categorical
variables (13). A p value 0.05 was considered significant.
RESULTS
EPS and ECG findings. The findings of a short PR
interval with a wide, slurred QRS complex on the ECG
were consistent with manifest ventricular pre-excitation,







Age (weeks) 6.5  2.9 7.9  3.6 6.8  2.9
SCL (ms) 260  119* 174  62 197  66
PR (ms) 9.8  2.7*† 27.3  3.7 30.9  3.7
QRS (ms) 17.0  2.6*† 13  2 12.9  1.0
JT (ms) 11.0  5.2 9.7  3.0 9.5  3.2
QT (ms) 31.2  7.1*† 22.7  2.9 22.4  3.7
*p  0.05 compared with TGN4881  BPT mice. †p  0.05 compared with
TGWT mice. Data are presented as the mean value  SD.
SCL  sinus cycle length; TGN4881  BPT  transgenic PRKAG2 mutant mice
with bypass tract; TGN4881  BPT transgenic PRKAG2 mutant mice without bypass
tract; TGWT  transgenic PRKAG2 wild-type mice.
Abbreviations and Acronyms
AMP  adenosine monophosphate
AV  atrioventricular
CCh  carbamyl choline
EPS  electrophysiologic study
ERP  effective refractory period
HBE  His-bundle electrogram
MHC  myosin heavy chain
SVT  supraventricular tachycardia
VA  ventriculo-atrial
WPW  Wolff-Parkinson-White
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Figure 1. Two distinct AV pathways are present in mutant transgenic mice. (A) Electrocardiographic leads I, II (LI and LII), and aVF are shown, as well
as the His-bundle electrogram (HBE). Atrial pacing at 110 ms with conduction down the bypass tract for the first five beats and fusion of atrial (A) and
ventricular (V) intracardiac electrograms on the HBE. The sixth beat (arrow) and subsequent beats conduct with a longer PR interval and narrower QRS
complex, suggesting block in the bypass tract and conduction down the AV node. Note separation of the atrial and ventricular electrograms on the HBE
and the presence of a His potential (HIS). (B) The left panel displays ECG leads I, II, and aVF, as well as the HBE, and shows a premature atrial
extrastimuli (S2) delivered at a coupling interval of 105 ms and a drive train (S1) at 150 ms. All three beats conduct with a short PR interval and wide QRS
complex, suggestive of manifest pre-excitation down an accessory AV pathway. The middle panel displays the same electrograms, with the premature atrial
extrastimulus coupled at 100 ms. The first two beats conduct with a short PR interval and wide QRS complex, but the atrial extrastimulus conducts with
a longer PR interval and narrow QRS complex, and the A and V electrograms are separated by a clear HIS. This indicates that the accessory pathway is
refractory and conduction is via the AV node. The right panel displays the same electrograms in another mouse, with the atrial extrastimuli coupled at 75 ms
to the drive train at 150 ms. The first two beats and atrial extrastimuli conduct with a short PR interval and wide QRS complex; on the HBE, there is fusion
between the A and V electrograms, suggesting conduction down the accessory AV connection. The last beat is followed by retrograde atrial depolarization
(Echo), with a long VA time, suggesting retrograde conduction up the AV node.
944 Patel et al. JACC Vol. 42, No. 5, 2003
Ventricular Pre-Excitation in a Mouse Model September 3, 2003:942–51
present in 8 of 17 TGN488I mice. Based on these initial
ECG features, TGN488I mice were classified into two
groups: those with apparent pre-excitation (TGN488IBPT)
and without pre-excitation (TGN488IBPT). The ECG inter-
vals (Table 1) revealed a slower resting heart rate with a shorter
PR interval and wider QRS complex in TGN488IBPT com-
pared with TGN488IBPT mice. Heart rates and ECG intervals
were similar among TGN488IBPT and TGWT mice. The
ECG and EPS data in TGWT mice are similar to control FVB
nontransgenic mice (data not shown).
To demonstrate the presence of an additional AV con-
nection and elucidate the electrophysiologic effects of the
N488I mutation, intracardiac EPS were performed. Atrial
pacing and programmed stimulation could induce accessory
pathway block, resulting in conduction down the AV node,
identified by HBE potentials during accessory pathway
refractoriness (Fig. 1). The EPS also established that
AV intervals were shorter in TGN488IBPT mice than in
TGN488I-BPT and TGWT mice (Table 2). The AV node
effective refractory period (ERP) was longer in TGN488IBPT
mice and the ventricular ERP was longer in both
TGN488IBPT and TGN488IBPT mice than in TGWT mice.
Retrograde conduction up the accessory connection was
robust at baseline, with 1:1 ventriculo-atrial (VA) conduc-
tion at cycle lengths of 50 ms in all TGN488IBPT mice.
However, procainamide induced retrograde accessory path-
way block with ventricular pacing at 100 ms, shifting
retrograde conduction up the AV node (Fig. 2). Pacing and
programmed stimulation, with or without isoproterenol, did
not induce SVT, although re-entrant echo beats could be
provoked.
Pharmacologic findings. To further confirm the presence
of a separate AV connection in TGN488I mice, we observed
the effect of procainamide and adenosine on the ECG
intervals and AV conduction. Intravenous procainamide
prolonged the PR interval and narrowed the QRS complex
in six of eight TGN488IBPT mice (Fig. 3A). Procainamide
lengthened the AV Wenckebach cycle length in these six
TGN488IBPT mice (85  8 ms vs. 142  13 ms, p 
0.001). Intravenous adenosine during atrial pacing resulted
in AV block in six of six TGWT mice but zero of six
TGN488IBPT mice (Fig. 3B).
Neonatal development of pre-excitation. To investigate
the natural history of pre-excitation induced by the
PRKAG2 mutation, we performed serial ECG analysis in a
cohort of 16 neonatal mice. Immediately after birth, no pups
showed evidence of pre-excitation, but by the first postnatal
week, two of eight TGN488I pups displayed pre-excitation.
This increased to seven (88%) of eight TGN488I pups by
postnatal week 4 (Fig. 4). None of the eight wild-type pups
showed pre-excitation through 12 weeks. By week 9, one
TGN488IBPT mouse lost pre-excitation on the ECG,
confirmed by EPS (Fig. 5).
By employing ECG algorithms for localizing human
accessory pathways (11), 10 of 12 TGN488IBPT mice
appeared to develop anteroseptal accessory AV connections;
one was posteroseptal and one was anterolateral by delta
wave vector analysis (Fig. 6A). We attempted to directly
identify the anatomic location of the bypass tracts by
comparing histologic findings on hearts from 1- and 2.5-
week-old TGN488I, TGWT, and wild-type mice. Two ani-
mals from each cohort underwent ECG recording; then, the
hearts were removed and serially sectioned. Histologic
assessment revealed myocardial connections through the
annulus fibrosis of the AV valves of both 2.5-week-old
TGN488I mice, but not in the other mice analyzed. Atrio-
ventricular connections were present in the right anterosep-
tal region of hearts from both TGN488I mice with WPW
syndrome at 2.5 weeks of age, concordant with the ECG
vector analysis (Fig. 6B). Histologically, these connections
resembled ventricular muscle and appeared similar to those
described in humans (14). No discernable AV connections
were identified in the hearts of one-week-old TGN488I or
TGWT mice and wild-type animals at either age.
Electrophysiologic assessment in older TGN488I mice. A
separate group of 10 older TGN488I and wild-type mice
underwent EPS. Of these, 7 of 10 TGN488I mice manifested
pre-excitation, and all 10 had intact AV conduction. How-
ever, the sinus cycle length was slower in preexcited
TGN488I mice (338  52 ms, p  0.001) compared with
non–pre-excited older mice (226  48 ms) or younger
preexcited TGN488I mice (251  50 ms). Spontaneous,
nonsustained SVT, atrial bigeminy, marked sinus bradycar-
dia, and pauses up to 1.6 s were seen in older TGN488I mice.
Atrioventricular node and accessory pathway conduction
characteristics were similar between 9- to 14-month-old
and 4- to 16-week-old TGN488I mice.







Age (weeks) 7.0  3.7 9.9  4.6 7.6  3.3
SCL (ms) 251  50 202  40 219  59
AH (ms) 23.6  5.1 26.9  4.6
Hd (ms) 4.6  0.7 4.9  1.0
HV (ms) 9.8  1.7 10.8  2.1
AVI (ms) 9.7  4.1*† 34.2  6.0 37.8  6.0
AERP150 (ms) 41.9  7.0‡ 38.3  7.5 33.9  7.4
AVERP150 (ms) 106  18.5‡ 86.1  15.6
BPERP150 (ms) 60.0  7.6
AVWBCL (ms) 116  13 108  19
AV 2:1 (ms) 102  14.7 88.3  14.8
BPWBCL (ms) 78.1  11.0
BP 2:1 (ms) 61.3  10.3
VAWBCL (ms) 50 119  25 125  14
VERP150 (ms) 56.4  11.8†‡ 55.0  10.4 30.6  10.1
*p  0.05 compared with TGN4881  BPT mice. †p  0.05 compared with
TGWT mice. ‡p  0.05 compared with TGWT mice. Data are presented as the mean
value  SD.
AH  atrio-Hisian interval; Hd  His duration; HV  His-ventricular interval;
AVI  atrioventricular interval; AERP150  atrial effective refractory period (ERP)
at drive train of 150 ms; AVERP150  atrioventricular ERP at drive train of 150 ms;
BPERP150  bypass tract anterograde ERP at drive train of 150 ms; AVWBCL 
atrioventricular Wenckebach block cycle length; AV 2:1  atrioventricular 2:1 block
cycle length; BPWBCL  bypass tract anterograde Wenckebach block cycle length;
BP 2:1  bypass tract 2:1 block cycle length; VAWBCL  ventriculoatrial
Wenckebach block cycle length; VERP150  ventriculoatrial effective refractory
period at drive train of 150 ms; other abbreviations as in Table 1.
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Carbamyl choline was administered and the atrial pacing
protocol repeated in an attempt to induce atrial fibrillation
and assess accessory pathway conduction (10). The CCh
dose utilized, determined by a dose-response curve (data not
shown), led to a 20% heart rate decrease and shortening of
atrial refractoriness (atrial ERP150 55 9 ms before CCh
vs. 43  8 ms after CCh, p  0.05). A stable heart rate was
observed within 5 min of intraperitoneal CCh and main-
tained for 30 min, considered effective cholinergic stimula-
tion. However, atrial pacing did not provoke atrial fibrillation
in any TGN488I mice; thus, anterograde accessory pathway
conduction during atrial fibrillation could not be assessed.
DISCUSSION
A missense mutation in PRKAG2 induced accessory AV
connections in the murine heart. Several lines of evi-
dence support the formation of accessory AV connections
in this transgenic model. Programmed electrical stimu-
lation in TGN488I mice switched the ECG pattern to
produce a longer PR interval and narrow QRS complex, with
a distinct His potential on the HBE recording, from one with
a short PR interval and a wide QRS complex with AV fusion
on the HBE. This suggests that the extrastimuli are blocked in
the accessory connection and conduct through the AV node.
Procainamide produced similar ECG and intracardiac effects,
with block induced in the accessory AV connection and
conduction transferred to the AV node. Further evidence for
an accessory AV connection is demonstrated by continued AV
conduction with adenosine in pre-excited TGN488I mice, but
adenosine-sensitive AV block in TGWT mice.
This transgenic mouse model recapitulates many pheno-
typic characteristics of human familial WPW syndrome.
Pre-excitation was present in 23% of patients in a family
from which the N488I mutation was derived (5). The EPS
performed in four individuals from another PRKAG2 family
showed seven accessory pathways at various locations (15).
Similarly, 14 of 28 TGN488I mice had accessory AV con-
nections with variable anatomic location. In TGN488I mice,
Figure 2. Retrograde conduction in mutant transgenic mice. Electrocardiographic leads I and II (LI and LII) are shown with right ventricular (RV EG)
and right atrial electrograms (RA EG). Ventricular pacing at 115 ms in the presence of procainamide, with retrograde conduction up the bypass tract for
the first eight beats and fusion of atrial (A) and ventricular (V) electrograms on both the RV EG and RA EG. The ninth beat (arrow) and subsequent beats
conduct with a longer RP interval, revealing retrograde block in the bypass tract and conduction up the AV node. Note there is now separation of the
A and V electrograms on both intracardiac electrograms.
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Figure 3. Pharmacologic effects on pre-excitation in mutant transgenic mice. (A) The left panel shows a six-lead electrocardiogram (ECG) at baseline, with
a short PR interval and wide, initially slurred QRS complex. The right panel shows the same six-lead ECG 2 min after procainamide infusion, which
lengthens the PR interval and narrows the QRS complex. The initial positive deflection of the QRS complex in leads I, II, III (LI, LII, and LIII), and
aVF in the left panel suggests an anteroseptal accessory AV pathway. (B) In the left panel, surface ECG leads I, II, and aVF, as well as the HBE, from
a wild-type mouse are displayed. Atrial pacing at 130 ms initially conducts 1:1 to the ventricles; however, adenosine infusion (arrow) produces AV block
with 2:1 conduction to the ventricles. In the right panel, the same ECG leads, along with the HBE, are displayed from a TGN488I mouse. Atrial pacing
at 100 ms conducts 1:1 to the ventricles, despite the presence of adenosine. A  atrial electrogram; AVB  atrioventricular block; His  His potential;
V  ventricular electrogram.
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Figure 4. Time course of developing pre-excitation in mutant transgenic mice. (A) The PR intervals from a cohort of 16 mice pups are plotted over 12
weeks. At birth (week 0), all pups have normal PR intervals without pre-excitation. By week 1, two of eight transgene positive mice (solid circles) develop
short PR intervals and pre-excitation, increasing to seven mice by week 4. No transgene-negative mice (open circles) had short PR intervals or
pre-excitation. (B) The top portion shows electrocardiogram (ECG) leads I, II (LI and LII), and aVF from a TGWT mouse. The PR interval remains
distinct and unchanged from birth through four weeks. The bottom portion displays the same ECG leads from a TGN488I mouse. At week 0, the PR
interval is similar to that of the TGWT mouse. By week 1, a short PR and wide QRS complex develop, suggestive of ventricular pre-excitation. At week
4, the PR interval remains short, with a wide QRS complex, sinus bradycardia, and sinus arrhythmia.
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AV connections were localized using vector analysis of the
initial QRS complex deflection, extrapolating ECG algo-
rithms derived from humans (11). Although these algo-
rithms were not designed for analysis of mouse ECGs, they
appear to localize the AV connections. In several TGN488I
mouse hearts, accessory AV connections anatomically cor-
related with the surface ECG “delta” wave vector axis (Fig.
6). Other electrophysiologic characteristics that this mouse
model recapitulates include sinus bradycardia and AV con-
duction disorders. Clinically, 31% of patients with the
N488I mutation developed sinus bradycardia; the sinus cycle
length of TGN488IBPT mice was longer than that of TGWT
mice. Also, 8% of these patients developed AV block and
15% required pacemakers (5). Although complete AV block
was not observed, AV node refractoriness was significantly
longer in TGN488I versus TGWT mice.
Despite firm evidence for the presence of an accessory AV
connection and observation of spontaneous, nonsustained
SVT in older TGN488I mice, orthodromic AV reciprocating
tachycardia could not be induced, even with isoproterenol or
procainamide. There are two potential reasons why SVT
could not be induced: 1) retrograde conduction up the
accessory AV connection is brisk (1:1 VA conduction
1,200 beats/min in all TGN488IBPT mice); and 2) most
had anteroseptal AV connections in close proximity to the
His-Purkinje system, which may be particularly germane in
the small murine heart. Together, these factors produce a
small re-entrant circuit with a rapid transit time, so the His
bundle cannot recover from refractoriness and maintain
tachycardia, even when bypass tract conduction is slowed.
Perhaps with a combination of advancing age, growth of the
heart, and slower VA conduction, these factors may be more
conducive for initiation and maintenance of SVT. In the
present series, mice were studied up to 15 months, whereas
the incidence of arrhythmia may increase with age, as in
humans with this mutation (5). In fact, we have observed
SVT, sinus bradycardia, and pauses in older mice (50
weeks) by single-lead telemetric ECG, including several
Figure 5. Loss of ventricular pre-excitation in a mutant mouse. (Top panel) Electrocardiographic leads I, II (LI and LII), and aVF displayed from a
TGN488I mouse. An electrocardiogram (ECG) pattern of pre-excitation is evident at postnatal week 2. At week 4, the phenotype was lost, but intermittent
pre-excitation returned in week 5. By week 7, the phenotype was completely lost, with a normal ECG. (Bottom panel) Electrocardiographic leads are
displayed, along with the HBE (EG). At week 10, adenosine infusion (arrow) during atrial burst pacing at 150 ms results in AV block with a slow
ventricular response. A  atrial electrogram; V  ventricular electrogram.
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episodes correlated with sudden bradycardic death (7).
However, on EPS, these mice did not have inducible AV
re-entrant tachycardia or atrial fibrillation.
Interestingly, during serial ECG recordings in newborns,
no TGN488I pups had pre-excitation immediately after birth.
After the first postnatal week, 25% of TGN488I mice showed
pre-excitation, increasing to 88% by week 4. Because the
transgene is under control of the murine alpha-MHC pro-
moter, we did not expect the phenotype to express until
postnatal life, as cardiac alpha-MHC expression increases
16-fold during the first postnatal week (16). This provides
evidence that the mutant PRKAG2 gene is responsible for
expression of the phenotype, but more intriguingly, the acces-
sory AV connections are induced in postnatal life after com-
pletion of cardiac organogenesis. This suggests that constitu-
tively activating AMP kinase mutations induce formation of
accessory AV connections, independent of septation and orga-
nogenesis. Although AMP kinase is known to regulate ribo-
nucleic acid transcription (17), the mechanism by which these
tracts form postnatally remains unknown. However, the ana-
tomic basis for pre-excitation in PRKAG2 mutants does not
appear to be failed resorption of embryonic AV tracts.
In this regard, we saw one PRKAG2 mutant mouse that
developed pre-excitation but lost the phenotype after several
weeks. The EPS with adenosine revealed no evidence of
accessory pathways, with a relatively short AV node ERP
(70 ms) and good anterograde AV node conduction (AV
Wenckebach node  85 ms). These data suggest that ion
channel remodeling may have induced concealment of the
AV connection in the anterograde direction (by enhancing
AV node conduction and slowing accessory tract conduc-
tion), rather than physical loss of the AV connection.
Another possibility is that late remodeling and fibrosis
anatomically altered the accessory connection and affected
its conductive properties. The AMP kinase modulates
adenosine triphosphate-dependent ionic conductance (18),
so accessory pathway conductance may increase by direct
effects of AMP kinase on ion channels. These cardiomyo-
cytes accumulate large amounts of cytoplasmic glycogen
(4–7), which can absorb water and alter the ionic en-
vironment and conductive properties. The accumulation
of cardiac glycogen may promote accelerated conduction,
as seen in Pompe’s disease, or contribute to disruption of the
annulus fibrosis, causing a novel acquired form of WPW
syndrome. The creation of this animal model allows for
molecular and basic electrophysiologic analyses to provide
further insight into the mechanisms governing the develop-
ment and maintenance of accessory AV pathways.
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Figure 6. Accessory connection localization in mutant transgenic mice. (A) Vector analysis of surface six-limb lead ECG recordings from three TGN488I
mice. In each panel, the solid line is placed at the onset of pre-excitation, and the dotted line is placed 5 ms later, intersecting the preexcited waveform. The left
panel shows a pattern consistent with an anteroseptal AV connection (leads I and aVL and leads II, III, and aVF are positive). The middle panel shows a pattern
consistent with a left lateral AV connection (leads I and aVL are negative and leads II, III, and aVF are positive), and the right panel shows a pattern of a
posteroseptal AV connection (lead I is isoelectric, lead aVL is positive, and leads II, III, and aVF are negative). (B) Masson trichrome-stained sections (5) from
one-week-old TGN488I (left panels) and 2.5-week-old TGN488I (right panels) hearts through the right paraseptal area anterior to the aortic outflow tract. The
fibrous separation between the atrial and ventricular myocardium is intact in the mutant heart from the one-week-old animal, whereas there is physical contact
between the atrial and vacuolated ventricular myocytes from the 2.5-week-old animal in the right anteroseptal region. Bottom inserts magnified 20.
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